<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="T3" position="float">
 <label>TABLE 3</label>
 <caption>
  <p>List of studies on the antioxidant effects of genus 
   <italic>Gynura.</italic>
  </p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th rowspan="1" colspan="1">Plant species</th>
    <th align="center" rowspan="1" colspan="1">Part, 
     <italic>Gynura</italic> form
    </th>
    <th align="center" rowspan="1" colspan="1">Cell line/Animal study model</th>
    <th align="center" rowspan="1" colspan="1">Concentration/dose, control groups</th>
    <th align="center" rowspan="1" colspan="1">Parameter measured and technique used</th>
    <th align="center" rowspan="1" colspan="1">Findings</th>
    <th align="center" rowspan="1" colspan="1">Reference</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td rowspan="7" colspan="1">
     <italic>Gynura procumbens</italic> (lour.) Merr
    </td>
    <td rowspan="5" colspan="1">Leaf</td>
    <td rowspan="6" colspan="1">Human HaCaT keratinocytes</td>
    <td align="left" rowspan="1" colspan="1">1, 10, 50 μg/ml</td>
    <td rowspan="7" colspan="1">Intracellular ROS production level by dichlorofluorescein (DCF) content</td>
    <td rowspan="7" colspan="1">GP extract treatment inhibited UV-induced ROS generation levels about 36% at 50 μg/ml</td>
    <td rowspan="7" colspan="1">
     <xref rid="B31" ref-type="bibr">Kim et al. (2011)</xref>
    </td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">Control groups</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> Normal control</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> Model control (UV 40 mJ/cm
     <sup>2</sup>)
    </td>
   </tr>
   <tr>
    <td rowspan="3" colspan="1"> Reference group (50, 100, 200 μg/ml vitamin C)</td>
   </tr>
   <tr>
    <td rowspan="2" colspan="1">Extract (ethanol)</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> 
     <italic>in vitro</italic> study stimulated by UV irradiation
    </td>
   </tr>
   <tr>
    <td rowspan="6" colspan="1"/>
    <td rowspan="3" colspan="1">Leaf</td>
    <td rowspan="5" colspan="1">Mice normal liver cell line NCTC-1469</td>
    <td rowspan="1" colspan="1">80 and 160 μg/ml (24 h)</td>
    <td rowspan="6" colspan="1">Intracellular ROS production level</td>
    <td rowspan="6" colspan="1">↓ ROS level by 80 and 160 μg/ml GP extract</td>
    <td rowspan="6" colspan="1">
     <xref rid="B41" ref-type="bibr">Liu Y. et al. (2019)</xref>
    </td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">Control groups</td>
   </tr>
   <tr>
    <td rowspan="2" colspan="1"> Normal control (culture medium)</td>
   </tr>
   <tr>
    <td rowspan="3" colspan="1">Extract (aqueous)</td>
   </tr>
   <tr>
    <td rowspan="2" colspan="1"> Model control (pre-treated with 0.25 mM palmitic acid (PA) + 0.5 mM oleic acid for 24 h)</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> 
     <italic>In vitro</italic> study stimulated by palmitic acid and oleic acid
    </td>
   </tr>
   <tr>
    <td rowspan="7" colspan="1"> </td>
    <td rowspan="2" colspan="1">Leaf</td>
    <td rowspan="2" colspan="1">18 sprague-dawley rats (6 rats/group)</td>
    <td rowspan="1" colspan="1">1.0 g/kg body weight</td>
    <td rowspan="4" colspan="1">Plasma lipid peroxidation levels using thiobarbituric acid reactive substances (TBARS) assay</td>
    <td rowspan="3" colspan="1">↓ plasma TBARS level</td>
    <td rowspan="7" colspan="1">
     <xref rid="B1" ref-type="bibr">Akowuah et al. (2012)</xref>
    </td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> Oral route</td>
   </tr>
   <tr>
    <td rowspan="5" colspan="1">Extract (methanol)</td>
    <td rowspan="5" colspan="1"> 
     <italic>In vivo</italic> study using carbon tetrachloride (CCl
     <sub>4</sub>)-induced oxidative stress rats
    </td>
    <td rowspan="2" colspan="1"> Daily single dose for 14 days</td>
   </tr>
   <tr>
    <td rowspan="4" colspan="1">TAS values of rats fed with the extract (1 g/kg) for 14 days followed by CCl
     <sub>4</sub> administration were comparable to values of control group
    </td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> Control groups</td>
    <td rowspan="3" colspan="1">Plasma total antioxidant status (TAS)</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> Normal control</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> Model control (single dose of CCl
     <sub>4</sub>)
    </td>
   </tr>
   <tr>
    <td rowspan="11" colspan="1"> </td>
    <td rowspan="10" colspan="1">Leaf</td>
    <td rowspan="6" colspan="1">30 adult male sprague-dawley rats (6 rats/group)</td>
    <td rowspan="1" colspan="1">250 and 500 mg/kg body weight</td>
    <td rowspan="2" colspan="1">Lipid peroxidation levels using TBARS assay</td>
    <td rowspan="7" colspan="1">↑ GST and SOD activities in treated rats (250 and 500 mg/kg)</td>
    <td rowspan="11" colspan="1">
     <xref rid="B68" ref-type="bibr">Shwter et al. (2014)</xref>
    </td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> Oral route</td>
   </tr>
   <tr>
    <td rowspan="2" colspan="1"> Daily for 10 weeks</td>
    <td rowspan="1" colspan="1">Glutathione-S-transferase (GST) activity</td>
   </tr>
   <tr>
    <td rowspan="8" colspan="1">Superoxide dismutase (SOD) activity</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">Control groups</td>
   </tr>
   <tr>
    <td rowspan="3" colspan="1"> Normal control (normal saline subcutaneous injections, 10% tween 20 oral administration)</td>
   </tr>
   <tr>
    <td rowspan="5" colspan="1"> 
     <italic>In vivo</italic> study using carcinogen-induced colon cancer rats
    </td>
   </tr>
   <tr>
    <td rowspan="4" colspan="1">↓ MDA level in treatment groups 250 and 500 mg/kg GP.</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> Carcinogen group (azoxymethane (AOM) subcutaneous injection +10% tween 20 oral administration)</td>
   </tr>
   <tr>
    <td rowspan="2" colspan="1"> Reference group (AOM, fluorouracil intraperitoneal injection)</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">Extract (ethanol)</td>
   </tr>
   <tr>
    <td rowspan="12" colspan="1"> </td>
    <td rowspan="3" colspan="1">Whole plant</td>
    <td rowspan="5" colspan="1">48 female sprague-dawley rats (6 rats/group)</td>
    <td rowspan="2" colspan="1">250 and 500 mg/kg body weight</td>
    <td rowspan="5" colspan="1">Plasma malondialdehyde (MDA) level using high-performance liquid chromatography (HPLC)</td>
    <td rowspan="1" colspan="1">↓ MDA level in treatment groups 250 and 500 mg/kg GP compared to postmenopausal control group at month 3 and month 6</td>
    <td rowspan="12" colspan="1">
     <xref rid="B52" ref-type="bibr">Nazri et al. (2019)</xref>
    </td>
   </tr>
   <tr>
    <td rowspan="11" colspan="1">↑ SOD, GSH-Px and CAT enzyme activities in treated rats (250 and 500 mg/kg) compared to postmenopausal control group. GP maintained SOD activity from month 3 to month 6</td>
   </tr>
   <tr>
    <td rowspan="2" colspan="1"> Oral route</td>
   </tr>
   <tr>
    <td rowspan="9" colspan="1">Extract (ethanol)</td>
   </tr>
   <tr>
    <td rowspan="3" colspan="1"> Daily for 24 weeks</td>
   </tr>
   <tr>
    <td rowspan="7" colspan="1"> 
     <italic>In vivo</italic> study using postmenopausal rats fed with cholesterol diet enriched with repeatedly heated palm oil
    </td>
    <td rowspan="1" colspan="1">Superoxide dismutase (SOD) activity</td>
   </tr>
   <tr>
    <td rowspan="4" colspan="1">Glutathione peroxidase (GSH-Px) activity</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">Control groups</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> Sham group (rats received basal diet)</td>
   </tr>
   <tr>
    <td rowspan="2" colspan="1"> Postmenopausal (PM) group (rats subjected to ovariectomy, received 2% cholesterol diet fortified with five-time heated palm oil (5HPO)</td>
   </tr>
   <tr>
    <td rowspan="2" colspan="1">catalase (CAT) activity</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> Positive control (10 mg/kg atorvastatin)</td>
   </tr>
   <tr>
    <td rowspan="11" colspan="1"> </td>
    <td rowspan="1" colspan="1">Leaf</td>
    <td rowspan="3" colspan="1">32 male C57BL/6 J mice (8 mice/group)</td>
    <td rowspan="1" colspan="1">500 and 1,000 mg/kg body weight</td>
    <td rowspan="2" colspan="1">Hepatic malondialdehyde (MDA) level</td>
    <td align="left" rowspan="4" colspan="1">↓↓ MDA level in treatment groups 500 and 1,000 mg/kg GP.</td>
    <td rowspan="11" colspan="1">
     <xref rid="B41" ref-type="bibr">Liu Y. et al. (2019)</xref>
    </td>
   </tr>
   <tr>
    <td rowspan="10" colspan="1">Extract (aqueous)</td>
    <td rowspan="4" colspan="1"> Oral route</td>
   </tr>
   <tr>
    <td rowspan="4" colspan="1">Glutathione peroxidase (GSH-Px) activity</td>
   </tr>
   <tr>
    <td rowspan="8" colspan="1"> 
     <italic>In vivo</italic> study using non-alcoholic steatohepatitis (NASH) mice
    </td>
   </tr>
   <tr>
    <td rowspan="7" colspan="1">↑↑ GSH-Px, CAT and HO-1 activities in treated mice (500 and 1,000 mg/kg)</td>
   </tr>
   <tr>
    <td rowspan="2" colspan="1"> Daily for 6 weeks</td>
   </tr>
   <tr>
    <td rowspan="2" colspan="1">catalase (CAT) activity</td>
   </tr>
   <tr>
    <td rowspan="2" colspan="1">Control groups</td>
   </tr>
   <tr>
    <td rowspan="3" colspan="1">Heme oxygenase 1 (HO-1) activity</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> Normal control (methionine- and choline-sufficient (MCS) diet)</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> Model control (methionine- and choline-deficient (MCD) diet)</td>
   </tr>
   <tr>
    <td rowspan="11" colspan="1">
     <italic>Gynura bicolor</italic> (roxb. Ex willd.) DC.
    </td>
    <td rowspan="1" colspan="1">Leaf</td>
    <td rowspan="5" colspan="1">Human umbilical vein endothelial cells</td>
    <td align="left" rowspan="2" colspan="1">Aqueous or ethanol extract at 1, 2 or 4% (v/v)</td>
    <td align="left" rowspan="3" colspan="1">ROS production level by 2′,7′-dichlorofluorescein (DCF) content</td>
    <td rowspan="4" colspan="1">Pre-treatments with aqueous or ethanol extract dose-dependently ↓ ROS level and preserved GSH content</td>
    <td rowspan="11" colspan="1">
     <xref rid="B12" ref-type="bibr">Chao et al. (2015)</xref>
    </td>
   </tr>
   <tr>
    <td rowspan="10" colspan="1">Extract (aqueous, ethanol)</td>
   </tr>
   <tr>
    <td rowspan="4" colspan="1"> 12 h pre-treatment</td>
   </tr>
   <tr>
    <td rowspan="4" colspan="1">catalase (CAT) activity</td>
   </tr>
   <tr>
    <td rowspan="7" colspan="1">Pre-treatment at 2 and 4% retained CAT and GSH-Px activities</td>
   </tr>
   <tr>
    <td rowspan="6" colspan="1"> 
     <italic>In vitro</italic> study treated by high glucose
    </td>
   </tr>
   <tr>
    <td rowspan="2" colspan="1">Control groups</td>
   </tr>
   <tr>
    <td rowspan="2" colspan="1">Glutathione (GSH) content</td>
   </tr>
   <tr>
    <td rowspan="2" colspan="1"> Control (5.5 mM glucose)</td>
   </tr>
   <tr>
    <td rowspan="2" colspan="1">Glutathione peroxidase activity (GSH-Px)</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> Model control (33 mM glucose)</td>
   </tr>
   <tr>
    <td rowspan="9" colspan="1"> </td>
    <td rowspan="3" colspan="1">Leaf</td>
    <td rowspan="8" colspan="1">PC12 cell line (rat adrenal gland pheochromocytoma)</td>
    <td align="left" rowspan="1" colspan="1">Aqueous extract at 0.25, 0.5 or 1%</td>
    <td align="left" rowspan="2" colspan="1">ROS level by 2′,7′-Dichlorofluorescein diacetate (DCFH-DA)</td>
    <td rowspan="9" colspan="1">GB pre-treatments ↑ GSH content, ↑ GSH-Px activity, concentration-dependently ↓ ROS level and ↑ catalase activity</td>
    <td rowspan="9" colspan="1">
     <xref rid="B97" ref-type="bibr">Yang et al. (2019)</xref>
    </td>
   </tr>
   <tr>
    <td rowspan="3" colspan="1">48 h pre-treatment</td>
   </tr>
   <tr>
    <td rowspan="3" colspan="1">Glutathione level (GSH)</td>
   </tr>
   <tr>
    <td rowspan="6" colspan="1">Extract (aqueous)</td>
   </tr>
   <tr>
    <td rowspan="2" colspan="1">Control groups</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">Glutathione peroxidase activity (GSH-Px)</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> Normal control</td>
    <td rowspan="3" colspan="1">CAT activity assay</td>
   </tr>
   <tr>
    <td rowspan="2" colspan="1"> Model control (H
     <sub>2</sub>O
     <sub>2</sub> stimulation)
    </td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> 
     <italic>In vitro</italic> study of H
     <sub>2</sub>O
     <sub>2</sub> induced injury
    </td>
   </tr>
   <tr>
    <td rowspan="12" colspan="1"> </td>
    <td rowspan="1" colspan="1">Leaf</td>
    <td rowspan="2" colspan="1">Male C57BL/6 mice (8 mice/group)</td>
    <td rowspan="4" colspan="1">0.25 or 0.5% 
     <italic>G. bicolor</italic> aqueous extract diet
    </td>
    <td rowspan="3" colspan="1">Hepatic GSH or GSSG content</td>
    <td rowspan="12" colspan="1">0.25% or 0.5% GB ↑ GSH content, ↓ GSSG, ↓ ROS levels, maintained GSH-Px, GR, and catalase activities</td>
    <td align="left" rowspan="12" colspan="1">
     <xref rid="B98" ref-type="bibr">Yin et al. (2017)</xref>
    </td>
   </tr>
   <tr>
    <td rowspan="11" colspan="1">Extract (aqueous)</td>
   </tr>
   <tr>
    <td rowspan="10" colspan="1"> 
     <italic>In vivo</italic> study using chronic ethanol consumption-induced hepatic injury mice model
    </td>
   </tr>
   <tr>
    <td rowspan="2" colspan="1">Glutathione peroxidase activity (GSH-Px)</td>
   </tr>
   <tr>
    <td rowspan="2" colspan="1"> Oral route</td>
   </tr>
   <tr>
    <td rowspan="3" colspan="1">Glutathione reductase (GR) and catalase</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> 6 weeks</td>
   </tr>
   <tr>
    <td rowspan="2" colspan="1">Control groups</td>
   </tr>
   <tr>
    <td rowspan="4" colspan="1">Hepatic ROS level using DCFH-DA</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> Normal control</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> Liquid diet group (without ethanol)</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> Ethanol diet group</td>
   </tr>
   <tr>
    <td rowspan="12" colspan="1">vivoA</td>
    <td rowspan="6" colspan="1">Leaf</td>
    <td rowspan="11" colspan="1">50 male Balb/cA mice (10 mice/group)</td>
    <td align="left" rowspan="1" colspan="1">0.25, 0.5, 1% GB diet</td>
    <td rowspan="1" colspan="1">ROS level by DCFH-DA</td>
    <td rowspan="3" colspan="1">GB at 3 doses</td>
    <td align="left" rowspan="12" colspan="1">
     <xref rid="B54" ref-type="bibr">Pai et al. (2019)</xref>
    </td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> Oral route</td>
    <td rowspan="3" colspan="1">Glutathione level (GSH)</td>
   </tr>
   <tr>
    <td rowspan="3" colspan="1"> 8 weeks</td>
   </tr>
   <tr>
    <td rowspan="9" colspan="1">↑ GSH content, ↑ GPX, ↑ GR, and ↑ catalase activities↓ ROS level in heart and kidney</td>
   </tr>
   <tr>
    <td rowspan="3" colspan="1">Glutathione peroxidase activity (GSH-Px)</td>
   </tr>
   <tr>
    <td rowspan="3" colspan="1">Control groups</td>
   </tr>
   <tr>
    <td rowspan="6" colspan="1">Extract (aqueous)</td>
   </tr>
   <tr>
    <td rowspan="2" colspan="1">Glutathione reductase (GR)</td>
   </tr>
   <tr>
    <td rowspan="2" colspan="1"> Normal control (standard mouse basal diet)</td>
   </tr>
   <tr>
    <td rowspan="3" colspan="1">CAT activity assay</td>
   </tr>
   <tr>
    <td rowspan="2" colspan="1"> Diabetic model control (40 mg/kg BW streptozotocin via i.p. injection for 5 days)</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> 
     <italic>In vivo</italic> streptozotocin-induced type 1 diabetic mice model
    </td>
   </tr>
   <tr>
    <td rowspan="11" colspan="1">
     <italic>Gynura divaricata</italic> (L.) DC.
    </td>
    <td rowspan="2" colspan="1">Leaf, stem</td>
    <td rowspan="5" colspan="1">60 male imprinting control region mice (15 mice/group)</td>
    <td rowspan="1" colspan="1">Diets with 1.2% and 4.8% GD</td>
    <td rowspan="2" colspan="1">Glutathione peroxidase activity (GSH-Px)</td>
    <td rowspan="1" colspan="1">1.2% GD ↑↑ T-SOD levels, ↓↓</td>
    <td align="left" rowspan="11" colspan="1">
     <xref rid="B96" ref-type="bibr">Xu et al. (2015)</xref>
    </td>
   </tr>
   <tr>
    <td rowspan="5" colspan="1"> Oral route</td>
    <td rowspan="2" colspan="1">MDA level 4.8% GD</td>
   </tr>
   <tr>
    <td rowspan="9" colspan="1">Lyophilized into powder</td>
    <td rowspan="2" colspan="1">Total superoxide dismutase activity (SOD)</td>
   </tr>
   <tr>
    <td rowspan="8" colspan="1">↑↑ GSH-Px level, ↑ T-SOD level, ↓ MDA level</td>
   </tr>
   <tr>
    <td rowspan="5" colspan="1">Lipid peroxidation level by MDA level assay</td>
   </tr>
   <tr>
    <td rowspan="6" colspan="1"> 
     <italic>In vivo</italic> study using high-fat diet and streptozotocin (STZ) induced type 2 diabetic mice
    </td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> Daily for 4 weeks</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">Control groups</td>
   </tr>
   <tr>
    <td rowspan="2" colspan="1"> Normal control (normal diet)</td>
   </tr>
   <tr>
    <td rowspan="2" colspan="1"/>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> Diabetic model control (high-fat diet (18% lard, 20% sugar, 3% egg yolk, 59% basal diet) and 100 mg/kg STZ)</td>
   </tr>
   <tr>
    <td rowspan="11" colspan="1"> </td>
    <td rowspan="1" colspan="1">Aerial part</td>
    <td rowspan="2" colspan="1">Male ICR mice (15 mice/group)</td>
    <td align="left" rowspan="2" colspan="1">Diets with 1%, 5% and 10% GD</td>
    <td rowspan="4" colspan="1">Hepatic glutathione peroxidase activity (GSH-Px)</td>
    <td rowspan="3" colspan="1">1% GD: ↑ GSH-Px level, ↑ T-SOD level</td>
    <td align="left" rowspan="11" colspan="1">
     <xref rid="B18" ref-type="bibr">Dong et al., (2019)</xref>
    </td>
   </tr>
   <tr>
    <td rowspan="10" colspan="1">Lyophilized into powder</td>
   </tr>
   <tr>
    <td rowspan="9" colspan="1"> 
     <italic>In vivo</italic> study using high-fat diet and streptozotocin (STZ) induced type 2 diabetic mice
    </td>
    <td rowspan="2" colspan="1"> Oral route</td>
   </tr>
   <tr>
    <td rowspan="3" colspan="1">5% GD: ↑ GSH-Px level, ↑↑ T-SOD level, ↓ 8-OHdG level</td>
   </tr>
   <tr>
    <td rowspan="3" colspan="1"> Daily for 4 weeks</td>
    <td rowspan="1" colspan="1">Hepatic total superoxide dismutase activity (SOD)</td>
   </tr>
   <tr>
    <td rowspan="4" colspan="1">Hepatic lipid peroxidation level by MDA level assay</td>
   </tr>
   <tr>
    <td rowspan="5" colspan="1">10% GD: ↑↑ GSH-Px level, ↑ T-SOD level, ↓ MDA level, ↓ 8-OHdG level</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">Control groups</td>
   </tr>
   <tr>
    <td rowspan="2" colspan="1"> Normal control (normal chow)</td>
   </tr>
   <tr>
    <td rowspan="2" colspan="1">Hepatic 8-hydroxy-2′-deoxyguanosine (8-OHdG) level using ELISA</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> Model control (high-fat diet (18% lard, 20% sugar, 3% egg yolk and 59% basal diet) and 100 mg/kg STZ)</td>
   </tr>
   <tr>
    <td rowspan="9" colspan="1">
     <italic>Gynura segetum</italic> (lour.) Merr
    </td>
    <td rowspan="5" colspan="1">Leaf</td>
    <td rowspan="6" colspan="1">Polymorphonuclear cells neutrophils (PMN)</td>
    <td rowspan="1" colspan="1">Extract: 6.25–100 μg/ml</td>
    <td rowspan="9" colspan="1">ROS production level by luminol method</td>
    <td rowspan="4" colspan="1">GS extract exhibited inhibitory activity upon activation by PMA (IC
     <sub>50</sub> = 1.41 ± 0.63 μg/ml) and zymosan (IC
     <sub>50</sub> = 2.63 ± 0.89 μg/ml)
    </td>
    <td rowspan="9" colspan="1">
     <xref rid="B100" ref-type="bibr">Yuandani et al. (2017)</xref>
    </td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">Compounds: 3.125–50 μg/ml</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">Control groups</td>
   </tr>
   <tr>
    <td rowspan="4" colspan="1"> Negative control (without sample)</td>
   </tr>
   <tr>
    <td align="left" rowspan="4" colspan="1">8,8′-(ethene-1,2-diyl)-dinaphtalene-1,4,5-triol revealed ROS inhibitory upon activation by PMA (IC
     <sub>50</sub> = 0.13 μM) and zymosan (IC
     <sub>50</sub> = 0.05 μM)
    </td>
   </tr>
   <tr>
    <td rowspan="4" colspan="1">Extract (methanol), isolated compounds from extract</td>
   </tr>
   <tr>
    <td rowspan="3" colspan="1"> 
     <italic>In vitro</italic> study induced by opsonized zymosan or PMA
    </td>
   </tr>
   <tr>
    <td rowspan="2" colspan="1"> Positive control (acetylsalicylic acid)</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">Rutin inhibited ROS activated by PMA (IC
     <sub>50</sub> = 0.08 μM) and zymosan (IC
     <sub>50</sub> = 0.13 μM)
    </td>
   </tr>
   <tr>
    <td rowspan="10" colspan="1">
     <italic>Gynura nepalensis</italic> DC.
    </td>
    <td rowspan="4" colspan="1">Leaf</td>
    <td rowspan="3" colspan="1">H9c2 cardiomyoblasts</td>
    <td align="left" rowspan="1" colspan="1">0.78, 1.56, 3.12, 6.25, 12.5, 25, 50, 100 μM</td>
    <td rowspan="5" colspan="1">Intracellular ROS production by DCF content</td>
    <td align="left" rowspan="6" colspan="1">Compound 6 (3,5-dicaffeoylquinic acid ethyl ester) exhibited a more potent cytoprotective effect thus selected for further evaluation</td>
    <td rowspan="10" colspan="1">
     <xref rid="B99" ref-type="bibr">Yu et al. (2016)</xref>
    </td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> 1 h pre-treatment</td>
   </tr>
   <tr>
    <td rowspan="5" colspan="1">Control groups</td>
   </tr>
   <tr>
    <td rowspan="7" colspan="1"> 
     <italic>In vitro</italic> study stimulated by H
     <sub>2</sub>O
     <sub>2</sub>
    </td>
   </tr>
   <tr>
    <td rowspan="6" colspan="1">Nine caffeoylquinic acid analogs (1–9) isolated from ethanol extract</td>
   </tr>
   <tr>
    <td rowspan="5" colspan="1">CAT activity assay</td>
   </tr>
   <tr>
    <td rowspan="3" colspan="1">↓↓↓ ROS production in H
     <sub>2</sub>O
     <sub>2</sub>-treated cells, even at a concentration of 0.78 μM
    </td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> Normal control</td>
   </tr>
   <tr>
    <td rowspan="2" colspan="1"> Model control (0.3 mM H
     <sub>2</sub>O
     <sub>2</sub>)
    </td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">↑↑↑ H
     <sub>2</sub>O
     <sub>2</sub>-induced decrease in CAT activity at doses of 25 and 50 μM
    </td>
   </tr>
   <tr>
    <td rowspan="10" colspan="1">
     <italic>Gynura formosana</italic> kitam
    </td>
    <td rowspan="6" colspan="1">Leaf</td>
    <td rowspan="3" colspan="1">48 male sprague-dawley rats (8 rats/group)</td>
    <td rowspan="2" colspan="1">100 mg/kg, 250 mg/kg, 500 mg/kg body weight</td>
    <td rowspan="1" colspan="1">CAT activity assay</td>
    <td rowspan="10" colspan="1">250 and 500 mg/kg GF treatment ↑↑ activities of CAT, ↑↑ SOD, ↑↑ GSH and ↓↓ lipid peroxidation in rat liver</td>
    <td rowspan="10" colspan="1">
     <xref rid="B44" ref-type="bibr">Ma et al. (2017)</xref>
    </td>
   </tr>
   <tr>
    <td rowspan="2" colspan="1">Total superoxide dismutase activity (SOD)</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> Oral route</td>
   </tr>
   <tr>
    <td rowspan="7" colspan="1"> 
     <italic>In vivo</italic> study using cotton pellet-induced granuloma rat model
    </td>
    <td rowspan="2" colspan="1"> Once daily for 7 days</td>
    <td rowspan="1" colspan="1">Glutathione level (GSH)</td>
   </tr>
   <tr>
    <td rowspan="6" colspan="1">Lipid peroxidation level</td>
   </tr>
   <tr>
    <td rowspan="2" colspan="1">Control groups</td>
   </tr>
   <tr>
    <td rowspan="4" colspan="1">Extract (ethyl acetate)</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> Normal control</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> Model control (0.5% carboxymethylcellulose, 1 ml/kg)</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> Standard drug (4 mg/kg indomethacin)</td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <fn>
   <p>↑ indicates significantly induce (
    <italic>p</italic> &lt; 0.05), ↑↑ indicates significantly induce (
    <italic>p</italic> &lt; 0.01), ↑↑↑ indicates significantly induce (
    <italic>p</italic> &lt; 0.001), ↓ indicates significantly inhibit (
    <italic>p</italic> &lt; 0.05), ↓↓ indicates significantly inhibit (
    <italic>p</italic> &lt; 0.01), and ↓↓↓ indicates significantly inhibit (
    <italic>p</italic> &lt; 0.001).
   </p>
  </fn>
 </table-wrap-foot>
</table-wrap>
